Prosecution Insights
Prosecution Insights
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| Double-patenting + other | 2 (40%) |
| Multi-statute (no §101) | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BROWE, DAVID | 1 | 26.2% | +27.7% |
| LEE, HOI YAN NMN | 1 | 41.0% | +79.2% |
| ZARA, JANE J | 1 | 70.9% | +16.1% |
| RAO, PADMAJA S | 1 | 68.5% | +37.0% |
| RODRIGUEZ, RAYNA B | 1 | 33.1% | +20.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18251839 | TREATMENT OF RECURRENT GIOBLASTOMA WITH PERILLYL ALCOHOL | BROWE, DAVID | 17d overdue |
| 17251452 | PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES | RODRIGUEZ, RAYNA B | 55d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18248733 | COMBINATION OF POH AND REMDESIVIR FOR TREATMENT OF CNS INFECTIONS | LEE, HOI YAN NMN | 134d overdue |
| 18001082 | COMPOSITIONS AND METHODS FOR DELIVERING POLYNUCLEOTIDES | ZARA, JANE J | 118d overdue |
| 18251839 | TREATMENT OF RECURRENT GIOBLASTOMA WITH PERILLYL ALCOHOL | BROWE, DAVID | 17d overdue |
| 17251452 | PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES | RODRIGUEZ, RAYNA B | 55d |
| 17762878 | PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES | RAO, PADMAJA S | — |
| Art Unit | Apps |
|---|---|
| 1617 | 1 |
| 1693 | 1 |
| 1637 | 1 |
| 1627 | 1 |
| 1628 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18251839 | TREATMENT OF RECURRENT GIOBLASTOMA WITH PERILLYL ALCOHOL | BROWE, DAVID | 1617 | §103Other | Non-Final OA | 17d overdue | Pending | May 04, 2023 |
| 18248733 | COMBINATION OF POH AND REMDESIVIR FOR TREATMENT OF CNS INFECTIONS | LEE, HOI YAN NMN | 1693 | §103DP | Non-Final OA | 134d overdue | Pending | Apr 12, 2023 |
| 18001082 | COMPOSITIONS AND METHODS FOR DELIVERING POLYNUCLEOTIDES | ZARA, JANE J | 1637 | §103 | Final Rejection | 118d overdue | Pending | Dec 08, 2022 |
| 17762878 | PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES | RAO, PADMAJA S | 1627 | §103DP | Non-Final OA | — | Pending | Mar 23, 2022 |
| 17251452 | PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES | RODRIGUEZ, RAYNA B | 1628 | §102§103Other | Non-Final OA | 55d | Pending | Dec 11, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial